Evidence map›Paper›PMID 41847975›Full record

ArticleHuman vaccines & immunotherapeutics2026

Development and validation of immunological assays for preclinical evaluation of a novel bivalent typhoid conjugate vaccine.

Vinay Gavade, Chandrashekhar Kamat, Nikhil Avalaskar, Vinod Haridasyam, Somnath Sargar, Avinash Chavan, Vaibhav Jadhav, Saurabh Kadam, Balu Borude, Annamraju D Sarma and 2 more

Abstract readValidation Study
In one paragraph

Article in Human vaccines & immunotherapeutics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Vinay GavadeResearch and Development, Serum Institute of India Pvt. Ltd., Pune, India.
Chandrashekhar KamatResearch and Development, Serum Institute of India Pvt. Ltd., Pune, India.
Nikhil AvalaskarResearch and Development, Serum Institute of India Pvt. Ltd., Pune, India.
Vinod HaridasyamResearch and Development, Serum Institute of India Pvt. Ltd., Pune, India.
Somnath SargarResearch and Development, Serum Institute of India Pvt. Ltd., Pune, India.
Avinash ChavanResearch and Development, Serum Institute of India Pvt. Ltd., Pune, India.
Vaibhav JadhavResearch and Development, Serum Institute of India Pvt. Ltd., Pune, India.
Saurabh KadamResearch and Development, Serum Institute of India Pvt. Ltd., Pune, India.
Balu BorudeResearch and Development, Serum Institute of India Pvt. Ltd., Pune, India.
Annamraju D SarmaResearch and Development, Serum Institute of India Pvt. Ltd., Pune, India.
Asha MallyaResearch and Development, Serum Institute of India Pvt. Ltd., Pune, India.
Rajeev M DhereResearch and Development, Serum Institute of India Pvt. Ltd., Pune, India.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Currently there is no licensed bivalent typhoid conjugate vaccine against

Indexed as

Antibodies, BacterialTyphoid FeverTyphoid-Paratyphoid VaccinesAnimalsDiphtheria ToxoidEnzyme-Linked Immunosorbent AssayHumansImmunoglobulin GIndiaPolysaccharides, BacterialSalmonella paratyphi ASalmonella typhiSerum Bactericidal Antibody AssayTetanus ToxoidVaccines, ConjugateAntibodies, BacterialDiphtheria ToxoidImmunoglobulin GPolysaccharides, BacterialTetanus ToxoidTyphoid-Paratyphoid VaccinesVaccines, ConjugateBaby Rabbit ComplementConjugate vaccineCOPELISASBA

Identifiers

PMID41847975
PMCPMC13003851

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.